Performance of the L-PLUS BGMS by Persons With Diabetes Mellitus
User Performance of the L-PLUS Blood Glucose Monitoring System
1 other identifier
interventional
130
1 country
1
Brief Summary
L-PLUS (Lightning PLUS) is the code name of a blood glucose monitoring system (BGMS) consisting of a new meter and marketed CONTOUR PLUS® test strip. This clinical trial will assess the performance (accuracy) of the L-PLUS meter by lay users with diabetes enrolled as subjects in the study, and by health care professionals (also called study staff). The trial will follow the requirements and procedures described in ISO 15197:2013 International Standard.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2019
CompletedFirst Submitted
Initial submission to the registry
July 24, 2019
CompletedFirst Posted
Study publicly available on registry
July 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2019
CompletedResults Posted
Study results publicly available
June 13, 2024
CompletedJune 13, 2024
May 1, 2024
2 months
July 24, 2019
March 27, 2024
May 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of BGMS Compared to the Reference Analyzer - Fingerstick Blood Test
Accuracy of BGMS test with fingerstick blood. The results of the fingerstick meter test performed by the participant will be compared to results of the same blood on a laboratory reference analyzer using pre-specified accuracy criteria.
Day 1
Secondary Outcomes (2)
Accuracy of BGMS Compared to the Reference Analyzer - Palm Alternative Site Test (AST)
Day 1
Accuracy of BGMS Compared to the Reference Analyzer - Venous Blood
Day 1
Study Arms (1)
Untrained Subjects with Diabetes use the L-PLUS BGMS
EXPERIMENTALUntrained subjects with Diabetes test capillary fingerstick and palm blood (and study staff test subject fingerstick blood) using the L-PLUS BGMS. All blood glucose results are compared to reference method results obtained with subject capillary plasma. Also, study staff test venous blood and blood glucose results are compared to reference method results obtained from subject venous plasma.
Interventions
Blood Glucose Monitoring System
Eligibility Criteria
You may qualify if:
- Males and females, 18 years of age and older
- People with diabetes (PWD) - type 1 or type 2
- Ability to speak, read and understand English. Subjects must demonstrate ability to read a paragraph from the first page of the UG to qualify for the study.
- Willing to complete all study procedures
You may not qualify if:
- Hemophilia or any other bleeding disorder
- Pregnancy (self-reported)
- Physical, visual or neurological impairments that would make the person unable to perform testing with the BGMS.
- Previous participation in a blood glucose monitoring study using the Ascensia's Contour Next (Lightning Next) and Lightning PLUS (L-PLUS or Contour Plus ELITE) BGMS.
- Working for a medical laboratory, hospital or other clinical setting that involves training on or clinical use of blood glucose monitors.
- Being in this trial during or less than two days since xylose absorption testing (Xylose in the blood is known to cause interference).
- Working for a competitive medical device company, or having an immediate family member or someone who is not a family member but is living within the household of someone who works for such a company.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rainier Clinical Research Center, Inc.
Renton, Washington, 98057, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jane Wallace
- Organization
- Ascensia Diabetes Care
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2019
First Posted
July 26, 2019
Study Start
July 15, 2019
Primary Completion
September 5, 2019
Study Completion
September 5, 2019
Last Updated
June 13, 2024
Results First Posted
June 13, 2024
Record last verified: 2024-05